Innovate UK Knowledge Transfer Partnerships (KTPs) connect businesses with academic expertise to turn innovative ideas into real-world impact. The KTP is a collaboration between a postgraduate (Associate), a business, and a university (Knowledge Base, this involves the Principal investigators and Knowledge base office). The KTP between Queen Mary University of London (QMUL) and LIfT Biosciences has been awarded the highest possible “Outstanding” rating and a Certificate of E

- Members include Nobel laureate James P. Allison, Padmanee Sharma, Taha Merghoub, and Kingston Mills, who are all globally renowned experts in cancer immunotherapy and translational cancer immunology - LIfT BioSciences’ lead IMAN-based drug candidate is a groundbreaking next-generation immunotherapy designed to treat patients with treatment-resistant cancers London, May 07, 2026 – LIfT BioSciences (‘LIfT’ or ‘the Company’) today announced the formation of its Sci

Neutrophils, long considered short-lived immune cells, can be therapeutically targeted when their appropriate subset and functional state are identified for the disease context LIfT BioSciences’ immuno-modulatory alpha neutrophils (IMANs) are designed to have the potent anti-tumour activity of naturally occurring N1 neutrophils fixed into their biology London, April 22, 2026 – LIfT BioSciences (‘LIfT’ or ‘the Company’) today announced the publication of an article in Frontier